Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Parry Nutraceuticals, a division of EID Parry and part of the Murugappa Group, is a global leader in the production of microalgae-based health supplements. The company specializes in the cultivation and processing of organic Spirulina, Chlorella, and high-value carotenoids like Astaxanthin and Lycopene. With over two decades of experience, Parry operates large-scale, technology-driven cultivation facilities in India, adhering to international quality standards such as USP and organic certifications. Their products serve the global functional food, dietary supplement, and animal nutrition markets. The company is recognized for its sustainable manufacturing practices and rigorous quality control in the microalgae space.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Parry Nutraceuticals.